The Antibiotics Business Is Broken—But There's a Fix
Attempts to develop new antibiotics are failing because the projects aren’t profitable. To make new drugs, it seems, pharma companies need more money.
Related articles
-
Ex-Guatemalan presidential candidate sentenced in U.S. drug scheme
February 11, 2020 -
Nigerian military raids paper after Boko Haram article
January 7, 2019
